Background {#Sec1}
==========

Domestication of cats occurred in the Near East, probably by natural selection, the ancestor being the local feline subspecies, *Felis silvestris lybica* \[[@CR1]\]. From here, domestic cats (*Felis silvestris catus*) have spread world-wide with a current total population of kept or feral cats estimated at nearly one billion \[[@CR2]\]. With the exception of Australia, all inhabited continents also harbour indigenous felid species from which pathogens could conceivably be transferred to domestic cats. Feline babesiosis may be a case in point. Although cases of cats showing clinical signs of babesiosis have been reported sporadically from various countries, feline babesiosis seems to be an important disease of domestic cats only in South Africa, especially along the eastern and southern seaboard and with a few foci on the eastern escarpment \[[@CR3], [@CR4]\].

*Babesia felis* was described from a *c*.3-month-old wild-caught Sudanese wild cat (*Felis ocreata*, presumably a synonym of a *F. silvestris* subspecies) that was observed for 12 months but showed no overt clinical signs of disease \[[@CR5]\]. Parasitaemia, initially 0.5%, soon peaked at 8% (possibly due to stress while the host was adapting to captivity), but gradually decreased over a 3-month period and subsequently fluctuated around 0.4%. Blood from this cat was inoculated into 22 domestic cats. None of these cats showed any overt clinical signs of disease, but all developed a parasitaemia not exceeding 1% initially and then decreasing to a fluctuating low level which persisted indefinitely \[[@CR5]\]. Following the classification suggested by Wenyon \[[@CR6]\], Davis \[[@CR5]\] assigned the novel parasite to the genus *Babesia*; he did not designate and deposit a type-specimen, however, which led to subsequent confusion.

During the 1930s domestic cats exhibiting clinical signs similar to those of canine babesiosis, i.e. anaemia, icterus and lethargy, were occasionally presented to veterinarians in South Africa, especially in the Western Cape Province \[[@CR7], [@CR8]\]. *Felis caffra*, presumably the local subspecies of *F. silvestris*, was suspected as being a reservoir host \[[@CR8]\]. In the index case report of feline babesiosis \[[@CR7]\], the piroplasms seen on blood smears met the description of *B. felis* piroplasms by Davis \[[@CR5]\]. Due to its pathogenicity in domestic cats, in contrast to *B. felis* (*sensu stricto*), Jackson et al. \[[@CR7]\] proposed the name *Nuttalia felis* var. *domestica* for the South African organism. Choosing *Nuttalia* rather than *Babesia* as genus name, they followed Carpano et al. \[[@CR9]\] in preferring the classification by Du Toit \[[@CR10]\] rather than that of Wenyon \[[@CR6]\].

Regrettably, Jackson's \[[@CR7]\] conclusion that the South African organism represented a distinct taxon to *B. felis* (*s.s*.), being at least a local variety of the latter, was overlooked in subsequent reports on clinical manifestation and treatment of feline babesiosis: the causative organism was merely referred to as *B. felis* \[[@CR11]--[@CR13]\]. This was also the name used when details of molecular characterisation of the *Babesia* sp. causing disease in cats were deposited in the GenBank database \[[@CR14]\]. The matter will only be resolved if Davis's \[[@CR5]\] original specimens are traced, which seems unlikely. Molecular characterisation has since revealed the presence of *B. felis* (*sensu lato*) in cheetahs (*Acinonyx jubatus*), lions (*Panthera leo*) and servals (*Leptailurus serval*) in South Africa, Namibia and Zambia \[[@CR15], [@CR16]\].

Domestic cats can also be infected with other *Babesia* spp. A large, unidentified *Babesia* was incriminated in causing severe clinical signs in a domestic cat in Harare, Zimbabwe \[[@CR17]\]. When examining blood smears of sick cats in South Africa, veterinarians occasionally report finding large organisms (Fig. [1](#Fig1){ref-type="fig"}), resembling *Babesia rossi* of dogs rather than the small *B. felis* (*s.l.*) (Figs. [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}); attempts at identifying these organisms were unsuccessful (pers. obs.). *Babesia canis* subsp. *presentii* was described from two cats in Israel, one a subclinical carrier and the other suffering from co-infection of various other pathogens \[[@CR18]\].Fig. 1Blood smear from a cat with clinical signs of babesiosis, showing large, extracellular piroplasms (Courtesy: Dr James Hill, Vetdiagnostix, Pietermaritzburg) Fig. 2Blood smear from a cat with clinical signs of babesiosis, showing small, intra-erythrocytic *Babesia felis* (*sensu lato*) piroplasms (Courtesy: Dr Sandy Weltan, Vetdiagnostix, Cape Town) Fig. 3Blood smear from a cat with high parasitaemia of *Babesia felis* (*sensu lato*) piroplasms

*Babesia pantherae*, a large piroplasm isolated from leopards (*Panthera pardus*) in Kenya and *B. herpailuri* isolated from a jaguarundi (*Herpailurus yaguarondi*) originating from Venezuela could be established in domestic cats \[[@CR19]--[@CR21]\]. In both cases overt clinical signs developed only in asplenic cats; spleen-intact cats developed a long-lasting parasitaemia but remained asymptomatic \[[@CR19]\]. Unfortunately, this was before the advent of molecular characterisation of piroplasms.

A previous South African survey of cats with clinical signs consistent with babesiosis suggested the presence of further potentially pathogenic piroplasms \[[@CR15]\]. Subsequent molecular characterisation revealed that the pathogen involved in two fatal cases of feline babesiosis, one being the first record of cerebral babesiosis in a domestic cat, showed a high similarity with *B. lengau,* previously described from asymptomatic cheetahs \[[@CR22], [@CR23]\].

The aim of the present study was to characterise piroplasms from domestic cats in South Africa (Western Cape and KwaZulu-Natal) and Mozambique (Maputo) exhibiting clinical signs of babesiosis, using *18S* rRNA gene sequence data and phylogenetic analysis.

Methods {#Sec2}
=======

Blood samples from 18 domestic cats, submitted for diagnostic purposes by private veterinary practitioners to the Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, were included in the study (Table [1](#Tab1){ref-type="table"}). Inclusion criteria were clinical signs of babesiosis, identification of piroplasms on blood smears and/or positive reverse line blot (RLB) hybridization assay results. Except for one specimen from Maputo, Mozambique, all samples originated from coastal areas in the Western Cape and KwaZulu-Natal provinces of South Africa (Fig. [4](#Fig4){ref-type="fig"}).Table 1List of domestic cat samples used, with details on the origin, microscopic examination of blood smears, RLB results and phylogenetic classificationSample IDOriginMicroscopyRLB resultsNo. of clonesPhylogenetic classificationBF221Cascades, KZN, RSA*Babesia* spp.*Babesia* genus-specific onlyNot applicable^a^*B. leo*BF238Durban, KZN, RSA*Babesia* spp.*Babesia* genus-specific onlyNot applicable*B. leo*BF272Hermanus, WC, RSANo parasites seen*Babesia* genus-specific onlyNot applicable*B. felis*BF284Bellville, WC, RSALarge *Babesia* spp.*Babesia* genus-specific onlyNot applicable*B. felis*BF341Durban, KZN, RSA*Babesia* spp.*Babesia* genus-specific onlyNot applicable*B. leo*BF342Bellville, WC, RSALarge *Babesia* spp.Negative/Below detection limitNot applicableNovel *Babesia* sp. variant 1BF461Maputo, Mozambique*Babesia* spp.*Babesia* genus-specific onlyNot applicable*B. leo*BF472Durban, KZN, RSALarge *Babesia* spp.*B. felis*Not applicableNovel *Babesia* sp. variant 3BF475Durban, KZN, RSA*Babesia* spp.*B. felis*Not applicable*B. felis*Cat01Cape Town, WC, RSALarge *Babesia* spp.*B. felis*2Novel *Babesia* sp. variant 16Novel *Babesia* sp. variant 2Cat02Cape Town, WC, RSA*Babesia* spp.*B. felis*, *B microti*1*B. microti*5Novel *Babesia* sp. variant 15Novel *Babesia* sp. variant 3Cat03Cape Town, WC, RSA*Babesia* spp.Not tested5Novel *Babesia* sp. variant 11Novel *Babesia* sp. variant 2Cat05Sedgefield, WC, RSA*Babesia* spp.*B. felis*8*B. felis*Cat06Sedgefield, WC, RSA*Babesia* spp.*B. felis*9*B. felis*Cat07Pietermaritzburg, KZN, SALarge *Babesia* spp.Not tested1*B. leo*Cat08Paarl, WC, RSALarge *Babesia* spp.Not tested1Novel *Babesia* sp. variant 2Cat09Paarl, WC, RSALarge *Babesia* spp.Not tested1Novel *Babesia* sp. variant 1Cat10Durban, KZN, RSA*Babesia* spp.Not tested1*B. felis*^a^PCR amplicon directly sequenced (not subjected to cloning)*Abbreviations:* KZN, KwaZulu-Natal; RSA, Republic of South Africa; WC, Western Cape Province Fig. 4Map of Southern Africa showing the origin of the samples

DNA was extracted according to the manufacturer's instructions using the QIAamp^®^ DNA Mini Kit (Qiagen, Whitehead Scientific, South Africa). The V4 hypervariable region of the parasite *18S* rRNA gene was PCR amplified using *Babesia* and *Theileria* genus-specific primers RLB-F2 and biotin-labelled RLB-R2 \[[@CR24], [@CR25]\]; PCR reaction conditions were as described by Tembo et al. \[[@CR26]\]. DNA extracted from blood from a known *T. parva*-infected buffalo \[[@CR27]\] was used as a positive control, while PCR master mix without DNA was used as a negative control. A touch down thermal cycler programme was used to amplify the DNA \[[@CR25]\]. The PCR products were then analysed using the RLB hybridization technique as previously described \[[@CR24], [@CR25], [@CR28], [@CR29]\]. Genus- and species-specific probes as described by Tembo et al. \[[@CR26]\] were included on the membrane; in addition to this, a *B. lengau* probe \[[@CR22]\] was also included.

The near full-length parasite *18S* rRNA gene (\~1700 bp) was PCR amplified using primers Nbab_1F \[[@CR30]\] and TB Rev \[[@CR31]\], as previously described by Bosman et al. \[[@CR22]\]. Four separate reactions were prepared per sample. Amplicons of all four reactions per sample were pooled to avoid Taq polymerase-induced errors and purified using a QIAquick PCR purification kit (Qiagen, Southern Cross Biotechnology, South Africa) according to the manufacturer's instructions. Nine of the samples (labelled BF; Table [1](#Tab1){ref-type="table"}) that had been yielded positive RLB results in a previous study \[[@CR15]\], were subjected to direct (bi-directional) sequencing on an ABI 3500XL genetic analyser using the amplification primers. For the other nine specimens, PCR amplicons were cloned prior to sequencing (in case of mixed infections not being detected or masked by the RLB assay) into the pGEM-T Easy vector (Promega, Anatech, South Africa) and transformed into competent *Escherichia coli* JM109 cells (JM109 high-efficiency competent cells, Promega). Recombinant plasmids were directly (bi-directional) sequenced on the ABI 3500XL genetic analyser at Inqaba Biotechnical Industries using the vector primers SP6 and T7.

Sequences were assembled and edited using GAP 4 of the Staden package (Version 1.6.0 for Windows) \[[@CR32]\]. A search for homologous sequences was performed using BLASTn \[[@CR33]\]. The sequences were aligned with sequences of related genera from GenBank using ClustalX (Version 1.81 for Windows). Alignment files were also analysed with CLC Main Workbench version 4.0 (CLC bio, Aarhus, Denmark) to test consistency of the alignment. The alignment was manually truncated to the size of the smallest sequence (1421 bp). The genetic distances between the sequences were estimated by determining the number of nucleotide differences between sequences using MEGA version 7 \[[@CR34]\]. Phylogenetic trees were constructed by the Neighbor-Joining (NJ) and Maximum Likelihood (ML) methods as implemented in MEGA 7. The two-parameter model of Kimura \[[@CR35]\] was used to construct similarity matrices by single distance from the aligned sequence data; a NJ phylogenetic tree \[[@CR36]\] was constructed in combination with the bootstrap method (1000 replicates/tree) \[[@CR37]\]. The Hasegawa-Kishino-Yano (HKY + G + I) substitution model \[[@CR38]\], determined as the best-fit model using MEGA 7, was used to infer a ML tree in combination with the bootstrap method (1000 replicates/tree) \[[@CR37]\]. The *18S* rDNA sequences of *Cardiosporidium ciona* (EU052685), the closest species for which data are available according to Schnittger et al. \[[@CR39]\], was included as the outgroup. All consensus trees were edited using MEGA 7. The GenBank accession numbers of reference sequences used in this study are reported in Table [2](#Tab2){ref-type="table"}. The *18S* rRNA gene sequences obtained in this study were submitted to GenBank; the accession numbers are reported in Table [3](#Tab3){ref-type="table"}.Table 2Accession numbers for GenBank reference sequences used in the present studyGenBank IDSpeciesOriginHostReferencesAY072926*B. canis*CroatiaDogCaccio et al. \[[@CR52]\]AY272047*B. canis presentii*IsraelCatBaneth et al. \[[@CR18]\]AF158702*B. conradae*USADogKjemtrup et al. \[[@CR53]\]U16370*B. divergens*USACattleHolman \[[@CR54]\]AF158700*B. duncani*USAHumanKjemtrup et al. \[[@CR55]\]AF244912*B. felis*South AfricaDomestic catPenzhorn et al. \[[@CR40]\]AY278443*B. gibsoni*SpainDogCriado-Fornelio et al. \[[@CR56]\]GQ411417*B. lengau*South AfricaCheetahBosman et al. \[[@CR22]\]KC790443*B. lengau*South AfricaDomestic catBosman et al. \[[@CR23]\]KC833036*B. lengau*South AfricaDomestic catBosman et al. \[[@CR23]\]AF244911*B. leo*South AfricaLionPenzhorn et al. \[[@CR40]\]AY452708*B. leo*South AfricaDomestic catWuerth (unpubl.)AB071177*B. microti* (Munich)EuropeHumanTsuji et al. (unpubl.)AB119446*B. microti* (Otsu)JapanField rodentSaito-Ito et al. \[[@CR57]\]AF231348*B. microti* (GI)USAHumanZahler et al. \[[@CR58]\]AY693840*B. microti* (Gray)USAHumanSlemenda et al. (unpubl.)XR002459986*B. microti* (R1)USAHumanCornillot et al. \[[@CR59]\]U16369*B. odocoilei*USACervidHolman et al. \[[@CR60]\]AY661502*B. odocoilei*USABighorn sheepSchoelkopf et al. (unpubl.)M87565*B. rodhaini*AustraliaCell cultureEllis et al. \[[@CR61]\]DQ111760*B. rossi*SudanDogOyamada et al. \[[@CR62]\]AY190123*Babesia* sp. Akita610 Dog tickJapan*Ixodes ovatus*Inokuma et al. \[[@CR46]\]AB251608*Babesia* sp. MA\#230JapanRaccoonJinnai et al. \[[@CR44]\]KR017880*Babesia* sp. Maned wolfUSAManed wolfWasserkrug Naor et al. \[[@CR42]\]AB935172*Babesia* sp. YA23175JapanRaccoonKomura et al. (unpubl.)AB935330*Babesia* sp. SW-R-090616_T1JapanRaccoonHirata et al. (unpubl.)AB935331*Babesia* sp. SW-R-092616_T2JapanRaccoonHirata et al. (unpubl.)DQ028958*Babesia* sp. AJB-2006USARaccoonBirkenheuer et al. (unpubl.)KX218429*Babesia* sp. 1 1093 cl9BotswanaLionMcDermid et al. \[[@CR63]\]KX218430*Babesia* sp. 10 1092 cl9BotswanaLionMcDermid et al. \[[@CR63]\]KX218431*Babesia* sp. 3 1093 cl8BotswanaLionMcDermid et al. \[[@CR63]\]KX218432*Babesia* sp. 4 1093 cl2BotswanaLionMcDermid et al. \[[@CR63]\]KX218433*Babesia* sp. 5 1093 c17BotswanaLionMcDermid et al. \[[@CR63]\]KX218434*Babesia* sp. 6 1092 cl1BotswanaLionMcDermid et al. \[[@CR63]\]KX218435*Babesia* sp. 7 1092 cl3BotswanaLionMcDermid et al. \[[@CR63]\]KX218436*Babesia* sp. 8 1092 cl5BotswanaLionMcDermid et al. \[[@CR63]\]KX218437*Babesia* sp. 9 1093 cl1BotswanaLionMcDermid et al. \[[@CR63]\]KX218438*Babesia* sp. 10 1092 cl9BotswanaLionMcDermid et al. \[[@CR63]\]KX218439*Babesia* sp. 11 1095BotswanaLionMcDermid et al. \[[@CR63]\]KX218440*Babesia* sp. 12 1101BotswanaLionMcDermid et al. \[[@CR63]\]AF244913*Babesia* sp. Strain A CaracalSouth AfricaCaracalPenzhorn et al. \[[@CR40]\]AF244914*Babesia* sp. Strain B CaracalSouth AfricaCaracalPenzhorn et al. \[[@CR40]\]KF724377*B*. *venatorum*ChinaHumanSun et al. \[[@CR64]\]AY072925*B*. *vogeli*ItalyDogCaccio et al. \[[@CR52]\]EU052685*Cardiosporidium cionae*--*Ciona intestinalis*Ciancio et al. \[[@CR65]\] Table 3Accession numbers for the *18S* rRNA gene sequences generated in the present studyGenBank IDSamplePhylogenetic classificationOriginKC790441BF461^a^*B. leo*Maputo, MozambiqueKC790442BF472*Babesia* sp. Variant3Durban, KZN, RSAKC790444BF341A^a^*B. leo*Durban, KZN, RSAKR611115Cat05_8*B. felis*Sedgefield, WC, RSAKR611116Cat05_24*B. felis*Sedgefield, WC, RSAKR611117Cat05_18*B. felis*Sedgefield, WC, RSAKR611118Cat05_14*B. felis*Sedgefield, WC, RSAKR611119Cat05_13*B. felis*Sedgefield, WC, RSAKR611120Cat05_12*B. felis*Sedgefield, WC, RSAKR611121Cat05_6*B. felis*Sedgefield, WC, RSAKR611122Cat06_H5*B. felis*Sedgefield, WC, RSAKR611123Cat06_G5*B. felis*Sedgefield, WC, RSAKR611124Cat06_D5*B. felis*Sedgefield, WC, RSAKR611125Cat06_C5*B. felis*Sedgefield, WC, RSAKR611126Cat06_B6*B. felis*Sedgefield, WC, RSAKR611127Cat06_A6*B. felis*Sedgefield, WC, RSAKR611128Cat06_A5*B. felis*Sedgefield, WC, RSAKR611129Cat06_B5*B. felis*Sedgefield, WC, RSAKR611130Cat06_F5*B. felis*Sedgefield, WC, RSAKR611131Cat05_11*B. felis*Sedgefield, WC, RSAKR611132Cat07_5E*B. leo*Pietermaritzburg, KZN, RSAKR611133Cat03_5*Babesia* sp. Variant1Cape Town, WC, RSAKR611134Cat03_10*Babesia* sp. Variant1Cape Town, WC, RSAKR611135Cat03_3*Babesia* sp. Variant1Cape Town, WC, RSAKR611136Cat03_1*Babesia* sp. Variant1Cape Town, WC, RSAKR611137Cat02_3*Babesia* sp. Variant1Cape Town, WC, RSAKR611138Cat03_9*Babesia* sp. Variant1Cape Town, WC, RSAKR611139Cat02_6*Babesia* sp. Variant1Cape Town, WC, RSAKR611140Cat02_10*Babesia* sp. Variant1Cape Town, WC, RSAKR611141Cat02_12*Babesia* sp. Variant1Cape Town, WC, RSAKR611142Cat03_8*Babesia* sp. Variant2Cape Town, WC, RSAKR611143Cat02_4*Babesia* sp. Variant1Cape Town, WC, RSAKR611144Cat02_2*Babesia* sp. Variant3Cape Town, WC, RSAKR611145Cat02_1*Babesia* sp. Variant3Cape Town, WC, RSAKR611146Cat02_9*Babesia* sp. Variant3Cape Town, WC, RSAKR611148Cat02_13*Babesia* sp. Variant3Cape Town, WC, RSAKR611149Cat01_G*Babesia* sp. Variant1Cape Town, WC, RSAKR611150Cat01_K*Babesia* sp. Variant2Cape Town, WC, RSAKR611151Cat01_F*Babesia* sp. Variant1Cape Town, WC, RSAKR611152Cat01_A*Babesia* sp. Variant2Cape Town, WC, RSAKR611153Cat01_J*Babesia* sp. Variant2Cape Town, WC, RSAKR611154Cat01_I*Babesia* sp. Variant2Cape Town, WC, RSAKR611155Cat01_B*Babesia* sp. Variant2Cape Town, WC, RSAKR611156Cat01_E*Babesia* sp. Variant2Cape Town, WC, RSAKR611158Cat08_13*Babesia* sp. Variant2Paarl, WC, RSAKR611159Cat02_4b*Babesia* sp. Variant3Cape Town, WC, RSAKR732967BF475*B. felis*Durban, KZN, RSAKR732968BF284*B. felis*Bellville, WC, RSAKR732969BF272*B. felis*Hermanus, WC, RSAKR732970BF342*Babesia* sp. Variant1Bellville, WC, RSAKR732971BF461A^a^*B. leo*Maputo, MozambiqueKR732972BF341^a^*B. leo*Durban, KZN, RSAKR732973BF238*B. leo*Durban, KZN, RSAKR732974BF221*B. leo*Cascades, KZN, RSAKT182985Cat10_14_11*B. felis*Durban, KZN, RSAKT182986Cat9_8*Babesia* sp. Variant1Paarl, WC, RSAMK09534246Cat02_10b^b^*B. microti*Cape Town, WC, RSAMK09534346Cat02_10b_new^b^*B. microt*Cape Town, WC, RSA^a^Duplicate samples received per animal (BF341 and 461)^b^Sequences derived from the same clone (46Cat02_10b and 46Cat02_10b_new)*Abbreviations*: KZN, KwaZulu-Natal; RSA, Republic of South Africa; WC, Western Cape Province

Results {#Sec3}
=======

Clinical reports indicated that 15 cats showed severe clinical signs of babesiosis, e.g. lethargy, anaemia, icterus and fever. Although no detailed clinical reports were available for three cats (BF341, BF472 and BF455) (Table [1](#Tab1){ref-type="table"}), the attending veterinarians had made tentative diagnoses of babesiosis. With the exception of one cat (BF272), organisms morphologically consistent with piroplasms were seen on microscopic examination of blood smears from 17 of the cats; seven of these had been reported as a "large" *Babesia* (Table [1](#Tab1){ref-type="table"}).

The RLB hybridization assay results revealed that of the 13 samples tested, six (46.2%) tested positive for the presence of *B. felis* DNA. One of these samples (Cat02) had a mixed species infection with *B. microti* (Table [1](#Tab1){ref-type="table"}). This was subsequently confirmed by cloning and sequencing analysis of the *18S* rRNA gene. PCR amplicons from a further six samples (46.2%) hybridized with the *Babesia* genus-specific probe only, suggesting the presence of a potentially novel *Babesia* species. One sample (BF342) tested negative or below the detection limit of the assay although a large *Babesia* had been observed by microscopy.

A total of 55 nearly full-length (1484--1525 bp) parasite *18S* rRNA gene sequences were obtained from the 18 samples. Of these, nine were directly sequenced and the rest were cloned prior to sequencing, yielding a further 46 sequences from the clones (Table [1](#Tab1){ref-type="table"}). A BLASTn search revealed that sequences from six cats (two of from Durban, KwaZulu-Natal, and four from the Western Cape) were most closely related to a published *18S* rRNA gene sequence of *B. felis* (AF244912) which was previously described from a domestic cat and caused severe clinical babesiosis in naturally and experimentally infected cats in South Africa \[[@CR11], [@CR13]\]. One of these 21 sequences (Cat06_A6) had 100% sequence identity to the published *B. felis* sequence, while the remaining sequences had 99% identity, differing by one nucleotide from the published *B. felis 18S* rRNA gene sequence over a 1525 bp region.

Sequences from four cats had 100% identity with published *B. leo* sequences, while one sequence (Cat07_5E) had 99% identity with *B. leo* (with a 3 nucleotide difference over a 1520 bp region). *Babesia leo* was previously described from lions in the Kruger National Park, South Africa, and was shown to be a distinct species from *B. felis* and other felid piroplasms \[[@CR40]\]. One specimen was from Maputo, Mozambique, the other four being from KwaZulu-Natal, i.e. all on the north-eastern seaboard of southern Africa.

One sequence (Cat02new) had 98--100% sequence identity with published *B. microti 18S* rRNA gene sequences, including strains from the zoonotic *B. microti* lineages (USA, Munich, Kobe and Otsu/Hobetsu from Japan). It had 100% sequence identity to the published *B. microti* Otsu strain (AB119446) and differed by 3--6 nucleotides from the *B. microti* Gray (AY693840) and *B. microti* Munich (AB071177) strains, respectively.

The most interesting finding, however, was that sequences obtained from seven cats, six from the Western Cape Province and one from Durban, KwaZulu-Natal, constituted a novel *Babesia* group with 96% identity to *Babesia* spp. previously described from captive maned wolves (*Chrysocyon brachyurus*) \[[@CR41], [@CR42]\], raccoons (*Procyon lotor*) from the USA \[[@CR43]\] and Japan \[[@CR44], [@CR45]\] and from ticks collected from dogs in Japan \[[@CR46]\]. Three genetic variants were identified within this novel *Babesia* group (designated "Novel *Babesia* sp. genetic variants 1, 2 and 3"), differing by 1 to 3 nucleotides from each other. Genetic variant 1 was found in five cats, variant 2 in three cats and variant 3 in two cats (Table [2](#Tab2){ref-type="table"}). Three cats were infected with two genetic variants: two with variants 1 and 2, and one with variants 1 and 3.

The observed sequence similarities were subsequently confirmed by phylogenetic analyses. NJ and ML analyses were used to reveal the phylogenetic relationships between the near full-length *18S* rRNA gene sequences obtained from this study to related *Babesia* species previously deposited in GenBank (Table [1](#Tab1){ref-type="table"}). The topologies of both trees were similar. The ML tree is shown in Fig. [5](#Fig5){ref-type="fig"}. Three distinct clades, in concordance with Schnittger et al. \[[@CR39]\], were obtained representing Clade I (including rodent-infecting *B. microti* and *B. rodhaini*, and feline-infecting *B. leo* and *B. felis* parasites), Clade II (including *B. duncani* isolated from humans, canine *B. conradae* and *B. lengau* described from cheetah in South Africa) and Clade VI (*Babesia* (*s.s.*), including the canine-infecting *B. gibsoni*, *B. canis*, *B. rossi* and *B. vogeli*, the human-infecting isolate *B. venatorum*, as well as species infecting ungulates (such as *B. divergens* and *B. odocoilei*) and recently described *Babesia* species infecting other carnivores such as bears, cougars and raccoons, as well as field rodents. The novel *Babesia* species identified in this study grouped within Clade VI, also referred to as the "carnivore/rodent clade" by Schnittger et al. \[[@CR39]\].Fig. 5Maximum likelihood tree showing the evolutionary relationships of the *Babesia 18S* rDNA sequences obtained, with published sequences. The evolutionary history was inferred by using the Maximum Likelihood method based on the Hasegawa-Kishino-Yano model \[[@CR38]\]. A discrete Gamma distribution was used to model evolutionary rate differences among sites \[5 categories (+G, parameter = 0.4367)\]. The rate variation model allowed for some sites to be evolutionarily invariable \[(+I), 57.75% sites\]. The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. All positions containing gaps and missing data were eliminated. There were a total of 1208 positions in the final dataset. Evolutionary analyses were conducted in MEGA7 \[[@CR34]\]

Discussion {#Sec4}
==========

The *B. felis*-positive specimens were from both the Western Cape (*n* = 4) and KwaZulu-Natal (*n* = 2). There is a single report of *B. leo* from a sick cat, but it was a mixed infection with *B. felis* \[[@CR15]\]. The results of the present study unambiguously implicate *B. leo* in causing clinical babesiosis in domestic cats. The *B. leo*-positive specimens were all from the north-eastern seaboard of southern Africa: KwaZulu-Natal (*n* = 4) and Maputo, Mozambique (*n* = 1), which constituted the first record of *B. leo* from that country. The Kruger National Park, South Africa, from where *B. leo* was first described \[[@CR40]\], has a 320-km-long border with Mozambique. In a direct line, the south-eastern tip of the Park is only *c*.70 km from Maputo.

Sequence and phylogenetic analysis of the *18S* rRNA gene from seven cats showed that they harboured a novel *Babesia* sp. which segregated into three separate genetic variants in *Babesia* clade VI, the carnivore/rodent clade \[[@CR39]\]. *Babesia felis*, *B. leo* and *B. lengau*, the three South African felid piroplasms hitherto known to cause clinical signs in domestic cats, were relatively closely related \[[@CR15], [@CR22], [@CR40]\]. In contrast, the novel *Babesia* sp. reported here had only 92% sequence identity with *B. felis* (AF244912) and 89% sequence identity with *B. leo* (AF244911) and *B. lengau* (KC790443 and GQ411417), respectively. The *18S* rRNA gene has been widely used to characterize and classify previously unknown *Theileria* and *Babesia* parasites \[[@CR24], [@CR25], [@CR30], [@CR47]--[@CR49]\]. It has, however, not been established to what extent *18S* rRNA gene sequences must differ for the source organisms to be considered different species, rather than merely a genetic variant or genotype within a species \[[@CR50], [@CR51]\]. A single gene tree does not necessarily reflect a species tree \[[@CR39]\]; therefore, a tree should ideally be constructed using multiple genotypic characters of potentially different evolutionary histories \[[@CR39]\].

The novel genetic variants reported here were most closely related (96% identity) to a novel *Babesia* sp. reported from culled feral raccoons from Japan \[[@CR44], [@CR45]\] and from a clinically affected juvenile raccoon from the USA \[[@CR43]\]. It is tempting to speculate that feral raccoons may also have been the source of an incidental finding of this *Babesia* sp. in ticks collected from healthy dogs in Japan \[[@CR46]\]. The same *Babesia* sp. was incriminated in causing severe clinical babesiosis in two South American maned wolves from the same zoological park in Kansas, USA \[[@CR41], [@CR42]\].

When examining blood smears, veterinarians described the novel genetic variants reported here as "large" babesias. This may be the elusive large *Babesia* reported from cats in southern Africa. The arbitrary classification of babesias as either "large" or "small" is not satisfactory, however. For instance, the abovementioned *Babesia* sp. from raccoons was reported to be closely related to *B. odocoilei* and *B. divergens* \[[@CR44]\], both generally regarded as "large" species. Nevertheless, the mean length of the round, oval, amoeboid or piriform organisms was 3.13 ± 0.77 µm (range 1.25--4.8 µm) and the mean width was 2.5 ± 0.61 µm \[[@CR45]\]. Round, oval and amoeboid forms are trophozoites, which can be expected to increase in size. For comparative purposes, measuring newly formed merozoites should give more consistent and reliable results.

Six of the seven specimens of the novel genetic variants were from a fairly restricted area in the Western Cape Province (Bellville, Cape Town and Paarl). The other case was from Durban, KwaZulu-Natal. No further information was known about the latter case, e.g. whether the cat may originally have come the Cape Town area. It may be possible that the natural hosts and/or vectors of these novel genetic variants are restricted to the Western Cape Province. Due to lacking an appropriate type specimen, we refrain from describing a new species but refer to the novel organism as *Babesia* sp. cat Western Cape.

Further characterisation of this novel organism is warranted to understand the pathogenesis and epidemiology, as well as to develop appropriate diagnostic markers. Obtaining appropriate specimens poses a challenge, however. Veterinarians in the feline babesiosis-endemic area usually confirm a diagnosis by finding piroplasms on a blood smear and then treat the cat. Blood specimens are only rarely submitted for confirmation of a diagnosis. Furthermore, our laboratory is in Pretoria, *c*.600 km from Durban and 1500 km from Cape Town, which hampers routine sampling of clinical cases.

Conclusions {#Sec5}
===========

Our results indicate the presence of a novel potentially pathogenic *Babesia* sp. in felids in South Africa, which is not closely related to *Babesia felis*, *Babesia lengau* and *Babesia leo*, the three species known to be pathogenic to cats. Due to the lack of an appropriate type-specimen, we refrain from describing and a new species but refer to the novel organism as *Babesia* sp. Cat Western Cape.
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